| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1871 | 2023 |
| Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases M Sharifi-Rad, NV Anil Kumar, P Zucca, EM Varoni, L Dini, E Panzarini, ... Frontiers in physiology 11, 552535, 2020 | 1816 | 2020 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 1238 | 2022 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 505 | 2024 |
| Oxidative stress, free radicals and antioxidants: Potential crosstalk in the pathophysiology of human diseases P Chaudhary, P Janmeda, AO Docea, B Yeskaliyeva, AF Abdull Razis, ... Frontiers in chemistry 11, 1158198, 2023 | 479 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 473 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 471 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 453 | 2024 |
| Towards effective COVID‑19 vaccines: Updates, perspectives and challenges D Calina, AO Docea, D Petrakis, AM Egorov, AA Ishmukhametov, ... International journal of molecular medicine 46 (1), 3-16, 2020 | 413 | 2020 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The Lancet Gastroenterology & Hepatology 7 (7), 627-647, 2022 | 376 | 2022 |
| Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing HM Sadeghi, I Adeli, D Calina, AO Docea, T Mousavi, M Daniali, S Nikfar, ... International journal of molecular sciences 23 (2), 583, 2022 | 356 | 2022 |
| Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine P Dhyani, C Quispe, E Sharma, A Bahukhandi, P Sati, DC Attri, A Szopa, ... Cancer cell international 22 (1), 206, 2022 | 325 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 302 | 2024 |
| A new threat from an old enemy: Re‑emergence of coronavirus AO Docea, A Tsatsakis, D Albulescu, O Cristea, O Zlatian, M Vinceti, ... International journal of molecular medicine 45 (6), 1631-1643, 2020 | 302 | 2020 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 296 | 2023 |
| Pharmacological properties of chalcones: A review of preclinical including molecular mechanisms and clinical evidence B Salehi, C Quispe, I Chamkhi, N El Omari, A Balahbib, J Sharifi-Rad, ... Frontiers in Pharmacology 11, 592654, 2021 | 266 | 2021 |
| Diet, lifestyle and cardiovascular diseases: linking pathophysiology to cardioprotective effects of natural bioactive compounds J Sharifi-Rad, CF Rodrigues, F Sharopov, AO Docea, A Can Karaca, ... International journal of environmental research and public health 17 (7), 2326, 2020 | 255 | 2020 |
| Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits J Sharifi-Rad, C Quispe, M Imran, A Rauf, M Nadeem, TA Gondal, ... Oxidative medicine and cellular longevity 2021 (1), 3268136, 2021 | 247 | 2021 |
| Impact of natural compounds on neurodegenerative disorders: from preclinical to pharmacotherapeutics M Sharifi-Rad, C Lankatillake, DA Dias, AO Docea, MF Mahomoodally, ... Journal of Clinical Medicine 9 (4), 1061, 2020 | 247 | 2020 |
| The therapeutic potential of anthocyanins: current approaches based on their molecular mechanism of action B Salehi, J Sharifi-Rad, F Cappellini, Ž Reiner, D Zorzan, M Imran, ... Frontiers in pharmacology 11, 1300, 2020 | 245 | 2020 |
Anca Oana Docea (Mitrut)UMF Craiova, University of Medicine and Pharmacy CraiovaПотвърден имейл адрес: umfcv.ro
